BASE vs. ENFN, PDFS, OPRA, DCBO, EVBG, FSLY, VTEX, SPT, SOUN, and ZUO
Should you be buying Couchbase stock or one of its competitors? The main competitors of Couchbase include Enfusion (ENFN), PDF Solutions (PDFS), Opera (OPRA), Docebo (DCBO), Everbridge (EVBG), Fastly (FSLY), VTEX (VTEX), Sprout Social (SPT), SoundHound AI (SOUN), and Zuora (ZUO). These companies are all part of the "prepackaged software" industry.
Couchbase (NASDAQ:BASE) and Enfusion (NYSE:ENFN) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, institutional ownership, media sentiment, earnings, profitability, valuation, dividends and risk.
Couchbase received 38 more outperform votes than Enfusion when rated by MarketBeat users. Likewise, 46.53% of users gave Couchbase an outperform vote while only 18.75% of users gave Enfusion an outperform vote.
Enfusion has a net margin of 3.45% compared to Couchbase's net margin of -44.54%. Enfusion's return on equity of 10.30% beat Couchbase's return on equity.
Enfusion has lower revenue, but higher earnings than Couchbase. Couchbase is trading at a lower price-to-earnings ratio than Enfusion, indicating that it is currently the more affordable of the two stocks.
Couchbase has a beta of 0.72, suggesting that its share price is 28% less volatile than the S&P 500. Comparatively, Enfusion has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500.
Couchbase presently has a consensus price target of $32.40, indicating a potential upside of 24.33%. Enfusion has a consensus price target of $9.33, indicating a potential upside of 3.13%. Given Couchbase's stronger consensus rating and higher possible upside, equities analysts clearly believe Couchbase is more favorable than Enfusion.
In the previous week, Enfusion had 4 more articles in the media than Couchbase. MarketBeat recorded 9 mentions for Enfusion and 5 mentions for Couchbase. Couchbase's average media sentiment score of 0.47 beat Enfusion's score of 0.30 indicating that Couchbase is being referred to more favorably in the media.
96.1% of Couchbase shares are held by institutional investors. Comparatively, 81.1% of Enfusion shares are held by institutional investors. 16.1% of Couchbase shares are held by company insiders. Comparatively, 39.2% of Enfusion shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Summary
Couchbase and Enfusion tied by winning 9 of the 18 factors compared between the two stocks.
Get Couchbase News Delivered to You Automatically
Sign up to receive the latest news and ratings for BASE and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BASE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Couchbase Competitors List
Related Companies and Tools
